Alex T. Imholz
Deventer, OV, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Apparent diffusion coefficient metrics for treatment response assessment in soft tissue sarcoma: Reproducibility and prognostic value of whole-tumor and sub-regional analysis.
Journal: Skeletal radiology
Published: April 28, 2026
Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer.
Journal: British journal of clinical pharmacology
Published: May 08, 2025
Measurement variability of radiologists when measuring brain tumors.
Journal: European journal of radiology
Published: October 25, 2024
The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial.
Journal: ESMO open
Published: October 12, 2024
Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort.
Journal: Clinical pharmacokinetics
Published: June 24, 2024
70-Gene signature-guided adjuvant systemic treatment adjustments in early-stage ER+ breast cancer patients: 7-year follow-up of a prospective multicenter cohort study.
Journal: Breast cancer research and treatment
Published: June 06, 2024
Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective study.
Journal: British journal of cancer
Published: April 15, 2024
Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer.
Journal: ESMO open
Published: September 13, 2023
Enzalutamide Reduces Oxycodone Exposure in Men with Prostate Cancer.
Journal: Clinical pharmacokinetics
Published: April 18, 2023
Last Updated: 09/26/2026